News on Abraxis Pharmaceutical Products%2C Inc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Abraxis Pharmaceutical Products%2C Inc news from BioPortfolio.com Wed, 10 Feb 2010 05:56:26 GMT en Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039343&HITNO=0&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039343&THISHREF=http://c.moreover.com/click/here.pl%3fz2538043785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039343&HITNO=0&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039343&THISHREF=http://c.moreover.com/click/here.pl%3fz2538043785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038844&HITNO=1&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537798153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038844&HITNO=1&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537798153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038838&HITNO=2&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038838&THISHREF=http://c.moreover.com/click/here.pl%3fz2537796061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038838&HITNO=2&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038838&THISHREF=http://c.moreover.com/click/here.pl%3fz2537796061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: US pharma cos sue Lupin for patent infringementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=3&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=3&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! India: SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products For Distribution Across Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034087&HITNO=4&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034087&THISHREF=http://c.moreover.com/click/here.pl%3fz2535616533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034087&HITNO=4&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034087&THISHREF=http://c.moreover.com/click/here.pl%3fz2535616533%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: Transcept Pharmaceuticals Granted First U.S. Patent Coveringhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038038&HITNO=5&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038038&THISHREF=http://c.moreover.com/click/here.pl%3fz2537450604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038038&HITNO=5&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038038&THISHREF=http://c.moreover.com/click/here.pl%3fz2537450604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via MSN Money: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038568&HITNO=6&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038568&THISHREF=http://c.moreover.com/click/here.pl%3fz2537659267%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038568&HITNO=6&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038568&THISHREF=http://c.moreover.com/click/here.pl%3fz2537659267%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMontana's News Station: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038411&HITNO=7&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038411&THISHREF=http://c.moreover.com/click/here.pl%3fz2537597089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038411&HITNO=7&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038411&THISHREF=http://c.moreover.com/click/here.pl%3fz2537597089%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAtlanta Business Chronicle: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038400&HITNO=8&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038400&THISHREF=http://c.moreover.com/click/here.pl%3fz2537593214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038400&HITNO=8&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038400&THISHREF=http://c.moreover.com/click/here.pl%3fz2537593214%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038114&HITNO=9&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038114&THISHREF=http://c.moreover.com/click/here.pl%3fz2537475647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038114&HITNO=9&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038114&THISHREF=http://c.moreover.com/click/here.pl%3fz2537475647%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038043&HITNO=10&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038043&THISHREF=http://c.moreover.com/click/here.pl%3fz2537453712%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038043&HITNO=10&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038043&THISHREF=http://c.moreover.com/click/here.pl%3fz2537453712%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038031&HITNO=11&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038031&THISHREF=http://c.moreover.com/click/here.pl%3fz2537444828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038031&HITNO=11&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038031&THISHREF=http://c.moreover.com/click/here.pl%3fz2537444828%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038003&HITNO=12&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038003&THISHREF=http://c.moreover.com/click/here.pl%3fz2537422738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038003&HITNO=12&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038003&THISHREF=http://c.moreover.com/click/here.pl%3fz2537422738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038001&HITNO=13&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537421042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038001&HITNO=13&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537421042%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038000&HITNO=14&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038000&THISHREF=http://c.moreover.com/click/here.pl%3fz2537420673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038000&HITNO=14&MSIZE=237&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Abraxis%20Pharmaceutical%20Products,%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038000&THISHREF=http://c.moreover.com/click/here.pl%3fz2537420673%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: